FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LINZAGOLIX
异名/同义词3-(5-((2,3-DIFLUORO-6-METHOXYPHENYL)METHOXY)-2-FLUORO-4-METHOXYPHENYL)-2,4-DIOXO-1,2,3,4-TETRAHYDROTHIENO(3,4-D)PYRIMIDINE-5-CARBOXYLIC ACID
LINZAGOLIX
LINZAGOLIX [INN]
LINZAGOLIX [USAN]
LINZAGOLIX [WHO-DD]
OBE-2109
THIENO(3,4-D)PYRIMIDINE-5-CARBOXYLIC ACID, 3-(5-((2,3-DIFLUORO-6-METHOXYPHENYL)METHOXY)-2-FLUORO-4-METHOXYPHENYL)-1,2,3,4-TETRAHYDRO-2,4-DIOXO-
CAS登记号935283-04-8
物质唯一标识(Unique Ingredient Identifier)7CDW97HUEX
分子式C22H15F3N2O7S
国际化合物标识(International Chemical Identifier,InChI)BMAAMIIYNNPHAB-UHFFFAOYSA-N
SMILESO=c1n(-c2c(F)cc(OC)c(OCc3c(F)c(F)ccc3OC)c2)c(=O)[nH]c4csc(C(=O)O)c41
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System